|
| Status |
Public on Dec 28, 2015 |
| Title |
Treatment of primary effusion lymphoma cell lines with lenalidomide |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Technical replicates from BC3 and BCBL1 cell lines were treated with DMSO or 5 micromoles of lenalidomide for 24 hours.
NOTE: Detection p-values were neither computed nor used in this experiment. All data was processed directly from IDATs and the proportion of present probes estimated from the negative and positive controls.
|
| |
|
| Overall design |
8 samples, two technical replicates per cell line per condition.
|
| |
|
| Contributor(s) |
Triche TJ, Gopalakrishnan R, Chaudhary PM |
| Citation(s) |
26119939 |
| |
| Submission date |
Aug 21, 2014 |
| Last update date |
Aug 13, 2018 |
| Contact name |
Timothy J. Triche |
| Phone |
(323) 442-8072
|
| Organization name |
University of Southern California, Keck School of Medicine
|
| Department |
Norris Comprehensive Cancer Center
|
| Lab |
Hematology
|
| Street address |
1450 Biggy St., Harlyne Norris Research Tower 3509
|
| City |
Los Angeles |
| State/province |
CA |
| ZIP/Postal code |
90033 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
| Samples (8)
|
|
| Relations |
| BioProject |
PRJNA258655 |
Less...
More...